Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

CELUW

Celularity (CELUW)

Celularity Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CELUW
FechaHoraFuenteTítuloSímboloCompañía
24/05/202416:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELUWCelularity Inc
24/05/202416:15GlobeNewswire Inc.Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q FilingNASDAQ:CELUWCelularity Inc
15/05/202416:15Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CELUWCelularity Inc
14/05/202408:15GlobeNewswire Inc.Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T TherapyNASDAQ:CELUWCelularity Inc
22/04/202407:00GlobeNewswire Inc.Celularity Inc. to Host Investor and Analyst Research & Development DayNASDAQ:CELUWCelularity Inc
19/04/202416:30GlobeNewswire Inc.Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K FilingNASDAQ:CELUWCelularity Inc
18/04/202415:30GlobeNewswire Inc.Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024NASDAQ:CELUWCelularity Inc
15/04/202407:00GlobeNewswire Inc.Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial ProductsNASDAQ:CELUWCelularity Inc
08/04/202408:00GlobeNewswire Inc.Celularity to Present Data Showing Senescent Cell Elimination by Off-the-Shelf Natural Killer Cells Derived from Human Placental CellsNASDAQ:CELUWCelularity Inc
26/03/202408:00GlobeNewswire Inc.Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3LNASDAQ:CELUWCelularity Inc
20/03/202408:15GlobeNewswire Inc.Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular DystrophyNASDAQ:CELUWCelularity Inc
14/03/202408:15GlobeNewswire Inc.Celularity CEO to Present on Cell Therapy’s Potential to Improve Longevity at 2024 ABUNDANCE SummitNASDAQ:CELUWCelularity Inc
12/03/202408:20GlobeNewswire Inc.Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World CongressNASDAQ:CELUWCelularity Inc
07/03/202408:35GlobeNewswire Inc.Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental CellsNASDAQ:CELUWCelularity Inc
23/02/202415:10GlobeNewswire Inc.Celularity Announces 1-for-10 Reverse Stock SplitNASDAQ:CELUWCelularity Inc
 Showing the most relevant articles for your search:NASDAQ:CELUW